Stock PHAR PHARMING GROUP N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Pharming Group N.V. Nasdaq

Equities

PHAR

US71716E1055

Real-time Estimate Cboe BZX
Other stock markets
 10:25:25 2024-06-06 am EDT 		5-day change 1st Jan Change
8.725 USD +13.61% Intraday chart for Pharming Group N.V. -2.13% -23.53%
May. 31 Pharming Group Flags Delay in EU Review of Rare Immunodeficiency Drug MT
May. 30 Pharming Group N.V. Provides Update on Ongoing Regulatory Review of Leniolisib for the Treatment of Apds in the European Union CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
RBC Raises Price Target on Pharming Group to EUR2.10 From EUR1.95, Keeps Outperform Rating
MT
Oppenheimer Adjusts Pharming Group Price Target to $40 From $36, Maintains Outperform Rating
MT
Oppenheimer Adjusts Pharming Group's Price Target to $36 From $43, Maintains Outperform Rating
MT
Van Leeuwenhoeck issues research note on Pharming (PHAR.AS): Turning the Page
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHARM Stock
  4. PHAR Stock
  5. News Pharming Group N.V.
  6. Analyst Reco.